Abstract OC84 Table 1

Results

PHASE 1 Patients (8-week treatment from Jul-Sept 2022) and Week 16-20 review (Oct-Nov 2022)
Review NPRIMARY OUTCOMESECONDARY OUTCOMETERTIARY OUTCOME
Week 8 CCRPCRNCRCCRPCRNCRCCRPCRNCR
DGBI 16115011501150
IBD 3120120120
Week 16- 20 CCRPCRNCRCCRPCRNCRCCRPCRNCR
DGBI 16142014201420
IBD 3210120210
PHASE 2 Patients (8 -week treatment from Sept - Nov 2022)
Review N PRIMARY OUTCOME SECONDARY OUTCOME TERTIARY OUTCOME
Week 8 CCRPCRNCRCCRPCRNCRCCRPCRNCR
DGBI 16115011501150
IBD 3210210210
  • CCR (Complete Clinical Response) – Complete relief of symptom(s)

  • PCR (Partial Clinical Response) – Discernible improvement in symptom(s)

  • NCR (No Clinical Response) – No change in symptom(s) N= Number of patients